TrialJournal of clinical lipidology

Effects of atorvastatin on biomarkers of immune activation, inflammation, and lipids in virologically suppressed, human immunodeficiency virus-1-infected individuals with low-density lipoprotein cholesterol <130 mg/dL (AIDS Clinical Trials Group Study A5275).

Daniel E Nixon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.